openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings and cautions
5. WARNINGS AND PRECAUTIONS 5.1. Joint pain requires differential diagnosis for acute or subacute viral diseases, bacterial infection, pain due to overweight (leg joints) hyperuricemia syndrome, gout, and referred pain. 5.2. Patients with known sensitivity to salycilates should be monitored closely during the therapy, and should only be treated after successful application of a test dose without adverse effects. 5.3. Skin cleansing/disinfection is required before application. Saprophytic bacteria may produce injection site abscesses with improper skin preparation
6. ADVERSE REACTIONS 6.1. The most common mild adverse reaction is slight reddening at the injection site due to the mechanical effect of the needle or a superficial skin reaction of mild erythema.